In 2018, Congress finally passed one of Donald Trump’s priorities in his first campaign – the Right to Try Act. Trump had picked up on frustration with an overly bureaucratic Food and Drug Administration and its response to terminal or near-terminal diseases. While the process used by the FDA for drug approvals emphasizes safety, it can take a decade or more to get approvals, especially for rarer diseases that make multiple double-blind studies difficult to complete. Trump’s legislation allowed patients and families access to drugs in the study process and/or pending approval while waiving the risks of experimental treatment.
Advertisement
Read Full Article: https://hotair.com/ed-morrissey/2026/03/24/one-mother-asks-has-the-fda-torpedoed-the-right-to-try-n3813150
